However, because monoamine oxidase A breaks down not only serotonin but
also other monoamines like dopamine and noradrenaline, a
treatment that directly targets monoamine oxidase A could have a higher success rate, particularly in very serious cases: this
alternative is provided by selective and reversible monoamine - oxidase - A inhibitors.